Title : The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53.

Pub. Date : 2020 May 7

PMID : 32382008






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Overall, our studies suggest that USP10 could be a potential biomarker for predicting patient response to platinum, and that targeting USP10 could sensitize lung cancer patients lacking wild-type p53 to platinum-based therapy. Platinum tumor protein p53 Homo sapiens